Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lurdes Zamora

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Biomolecules|October 26, 2024
Quantification of Histone H1 Subtypes Using Targeted ProteomicsJordi López-Gómez, Laura Villarreal, Marta Andrés, et al.
HLA|December 18, 2021
Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemiaLaia Closa, Blanca Xicoy, Lurdes Zamora, et al.
Cancers|May 4, 2026
Different <i>SF3B1</i> Mutation Hotspots Show Hematopoietic Lineage-Specific VAF Patterns and Correlate with Distinct Genetic and Prognostic Profiles in Patients with Myeloid NeoplasmsOriol Calvete, Julia Mestre, Lurdes Zamora, et al.
Cancer Genetics and Cytogenetics|December 31, 2003
Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemiaElisabet Lloveras, Isabel Granada, Lurdes Zamora, et al.
Biopreservation and Biobanking|June 7, 2017
Inspecting Targeted Deep Sequencing of Whole Genome Amplified DNA Versus Fresh DNA for Somatic Mutation Detection: A Genetic Study in Myelodysplastic Syndrome PatientsLaura Palomo, Francisco Fuster-Tormo, Daniel Alvira, et al.
Annals of Hematology|September 7, 2016
CD34 expression and the outcome of nucleophosmin 1-mutated acute myeloid leukemiaJordi Juncà, Olga Garcia, Montse Garcia-Caro, et al.
Medicina Clinica|February 26, 2013
Frequency of ABL gene mutations in chronic myeloid leukemia patients resistant to imatinib and results of treatment switch to second-generation tyrosine kinase inhibitorsSilvia Marcé, Lurdes Zamora, Marta Cabezón, et al.
Hemasphere|December 2, 2021
Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia PatientsNatalia Estrada, Blanca Xicoy, Fabian Beier, et al.
Cancers|March 6, 2021
Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell ApproachPamela Acha, Laura Palomo, Francisco Fuster-Tormo, et al.
The American Journal of Pathology|September 6, 2002
Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome)Sílvia Beà, Armando López-Guillermo, Maria Ribas, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Biomolecules|October 26, 2024
Quantification of Histone H1 Subtypes Using Targeted ProteomicsJordi López-Gómez, Laura Villarreal, Marta Andrés, et al.
HLA|December 18, 2021
Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemiaLaia Closa, Blanca Xicoy, Lurdes Zamora, et al.
Cancers|May 4, 2026
Different <i>SF3B1</i> Mutation Hotspots Show Hematopoietic Lineage-Specific VAF Patterns and Correlate with Distinct Genetic and Prognostic Profiles in Patients with Myeloid NeoplasmsOriol Calvete, Julia Mestre, Lurdes Zamora, et al.
Cancer Genetics and Cytogenetics|December 31, 2003
Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemiaElisabet Lloveras, Isabel Granada, Lurdes Zamora, et al.
Biopreservation and Biobanking|June 7, 2017
Inspecting Targeted Deep Sequencing of Whole Genome Amplified DNA Versus Fresh DNA for Somatic Mutation Detection: A Genetic Study in Myelodysplastic Syndrome PatientsLaura Palomo, Francisco Fuster-Tormo, Daniel Alvira, et al.
Annals of Hematology|September 7, 2016
CD34 expression and the outcome of nucleophosmin 1-mutated acute myeloid leukemiaJordi Juncà, Olga Garcia, Montse Garcia-Caro, et al.
Medicina Clinica|February 26, 2013
Frequency of ABL gene mutations in chronic myeloid leukemia patients resistant to imatinib and results of treatment switch to second-generation tyrosine kinase inhibitorsSilvia Marcé, Lurdes Zamora, Marta Cabezón, et al.
Hemasphere|December 2, 2021
Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia PatientsNatalia Estrada, Blanca Xicoy, Fabian Beier, et al.
Cancers|March 6, 2021
Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell ApproachPamela Acha, Laura Palomo, Francisco Fuster-Tormo, et al.
The American Journal of Pathology|September 6, 2002
Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome)Sílvia Beà, Armando López-Guillermo, Maria Ribas, et al.
Pageof 7